Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

NCT00726713 is registered in ClinicalTrials.gov with Pamlab, Inc. as lead sponsor.

NCT NCT00726713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00726713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
Lead sponsor
Pamlab, Inc.
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2008
Completion date
June 30, 2011
Enrollment
214 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetic peripheral neuropathy (dpn)